Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Paul Rutgeerts(KU Leuven), Geert D’Haens(KU Leuven), Stephan R. Targan(Cedars-Sinai Medical Center), Eric Vasiliauskas(KU Leuven), Stephen B. Hanauer(KU Leuven), Daniel H. Present(KU Leuven), Lloyd Mayer(Mount Sinai Medical Center), R. A. van Hogezand(KU Leuven), Tanja Braakman(KU Leuven), Kimberly L. DeWoody(KU Leuven), T Schaible(KU Leuven), Sander J. H. van Deventer(Academic Medical Center)
Gastroenterology
October 1, 1999
10.1016/s0016-5085(99)70332-x
Cited by 1,093Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis